1. Home
  2. DPRO vs CING Comparison

DPRO vs CING Comparison

Compare DPRO & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DPRO
  • CING
  • Stock Information
  • Founded
  • DPRO 1998
  • CING 2012
  • Country
  • DPRO Canada
  • CING United States
  • Employees
  • DPRO N/A
  • CING N/A
  • Industry
  • DPRO Aerospace
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • DPRO Industrials
  • CING Health Care
  • Exchange
  • DPRO Nasdaq
  • CING Nasdaq
  • Market Cap
  • DPRO 17.3M
  • CING 14.4M
  • IPO Year
  • DPRO N/A
  • CING 2021
  • Fundamental
  • Price
  • DPRO $2.80
  • CING $4.27
  • Analyst Decision
  • DPRO Strong Buy
  • CING Strong Buy
  • Analyst Count
  • DPRO 2
  • CING 3
  • Target Price
  • DPRO $7.00
  • CING $16.00
  • AVG Volume (30 Days)
  • DPRO 130.9K
  • CING 118.1K
  • Earning Date
  • DPRO 03-26-2025
  • CING 03-31-2025
  • Dividend Yield
  • DPRO N/A
  • CING N/A
  • EPS Growth
  • DPRO N/A
  • CING N/A
  • EPS
  • DPRO N/A
  • CING N/A
  • Revenue
  • DPRO $4,340,793.00
  • CING N/A
  • Revenue This Year
  • DPRO $14.33
  • CING N/A
  • Revenue Next Year
  • DPRO $115.93
  • CING N/A
  • P/E Ratio
  • DPRO N/A
  • CING N/A
  • Revenue Growth
  • DPRO N/A
  • CING N/A
  • 52 Week Low
  • DPRO $1.55
  • CING $1.80
  • 52 Week High
  • DPRO $9.13
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • DPRO 37.04
  • CING 42.05
  • Support Level
  • DPRO $3.09
  • CING $4.22
  • Resistance Level
  • DPRO $3.34
  • CING $4.58
  • Average True Range (ATR)
  • DPRO 0.26
  • CING 0.32
  • MACD
  • DPRO -0.02
  • CING -0.04
  • Stochastic Oscillator
  • DPRO 2.80
  • CING 12.64

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: